Intra-Cellular Therapies, Inc. Quarterly Liabilities, Current in USD from Q4 2012 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
Summary
Intra-Cellular Therapies, Inc. quarterly Liabilities, Current history and growth rate from Q4 2012 to Q2 2024.
  • Intra-Cellular Therapies, Inc. Liabilities, Current for the quarter ending June 30, 2024 was $162M, a 75.7% increase year-over-year.
Liabilities, Current, Quarterly (USD)
Liabilities, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $162M +$69.7M +75.7% Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $135M +$55.2M +69.4% Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $124M +$40.3M +48.4% Dec 31, 2023 10-Q 2024-08-07
Q3 2023 $103M +$25.7M +33.2% Sep 30, 2023 10-Q 2023-11-02
Q2 2023 $92.1M +$21.4M +30.4% Jun 30, 2023 10-Q 2023-08-03
Q1 2023 $79.6M +$20.5M +34.7% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 $83.2M +$29.9M +56% Dec 31, 2022 10-K 2024-02-22
Q3 2022 $77.4M +$27.5M +55.1% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 $70.6M +$20.2M +40.1% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 $59.1M +$19.4M +48.8% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 $53.4M +$16.5M +44.8% Dec 31, 2021 10-K 2023-03-01
Q3 2021 $49.9M +$11.9M +31.2% Sep 30, 2021 10-Q 2021-11-09
Q2 2021 $50.4M +$10.2M +25.3% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 $39.7M +$8.63M +27.8% Mar 31, 2021 10-Q 2021-05-10
Q4 2020 $36.9M +$629K +1.74% Dec 31, 2020 10-K 2022-03-01
Q3 2020 $38M +$4.66M +14% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 $40.2M +$7.72M +23.7% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 $31.1M -$2.42M -7.23% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 $36.2M -$75.2K -0.21% Dec 31, 2019 10-K 2021-02-25
Q3 2019 $33.4M +$4.24M +14.6% Sep 30, 2019 10-Q 2019-11-05
Q2 2019 $32.5M +$13.6M +71.8% Jun 30, 2019 10-Q 2019-08-07
Q1 2019 $33.5M +$13.8M +70.5% Mar 31, 2019 10-Q 2019-05-08
Q4 2018 $36.3M +$22.1M +155% Dec 31, 2018 10-K 2020-03-02
Q3 2018 $29.1M +$17.3M +145% Sep 30, 2018 10-Q 2018-11-07
Q2 2018 $18.9M +$12M +172% Jun 30, 2018 10-Q 2018-08-02
Q1 2018 $19.7M +$3.33M +20.4% Mar 31, 2018 10-Q 2018-05-03
Q4 2017 $14.2M +$3.68M +34.9% Dec 31, 2017 10-K 2019-02-27
Q3 2017 $11.9M -$129M -91.6% Sep 30, 2017 10-Q 2017-11-08
Q2 2017 $6.96M -$12.4M -64.1% Jun 30, 2017 10-Q 2017-08-09
Q1 2017 $16.3M +$7.37M +82.4% Mar 31, 2017 10-Q 2017-05-10
Q4 2016 $10.5M +$4.27M +68.2% Dec 31, 2016 10-K 2018-03-01
Q3 2016 $141M +$130M +1254% Sep 30, 2016 10-Q 2016-11-09
Q2 2016 $19.4M +$10.1M +108% Jun 30, 2016 10-Q 2016-08-04
Q1 2016 $8.95M -$5.65M -38.7% Mar 31, 2016 10-Q 2016-04-28
Q4 2015 $6.26M -$4.29M -40.7% Dec 31, 2015 10-K 2017-03-01
Q3 2015 $10.4M +$6.81M +190% Sep 30, 2015 10-Q 2015-11-05
Q2 2015 $9.32M +$6.58M +240% Jun 30, 2015 10-Q 2015-08-05
Q1 2015 $14.6M +$10.7M +273% Mar 31, 2015 10-Q 2015-04-30
Q4 2014 $10.6M +$3.72M +54.5% Dec 31, 2014 10-K 2016-02-25
Q3 2014 $3.58M -$4.2M -54% Sep 30, 2014 10-Q 2014-11-03
Q2 2014 $2.74M -$30.3M -91.7% Jun 30, 2014 10-Q 2014-08-12
Q1 2014 $3.91M -$22.3M -85.1% Mar 31, 2014 10-Q 2014-05-05
Q4 2013 $6.83M +$3.99M +141% Dec 31, 2013 10-K 2015-03-12
Q3 2013 $7.77M Sep 30, 2013 10-Q 2013-11-05
Q2 2013 $33M Jun 30, 2013 10-Q 2013-08-15
Q1 2013 $26.2M Mar 31, 2013 10-Q 2013-08-15
Q4 2012 $2.84M Dec 31, 2012 10-K 2014-03-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.